Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05948371
Other study ID # REC/01653 Hafiza Misbah Inayat
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2023
Est. completion date December 15, 2023

Study information

Verified date March 2024
Source Riphah International University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To determine the effect of high intensity aerobic interval training versus continuous aerobic training in heart failure patients.


Recruitment information / eligibility

Status Completed
Enrollment 26
Est. completion date December 15, 2023
Est. primary completion date December 15, 2023
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient with heart failure including both male and female - Patients who can perform 6 MWT. - According to classification of American heart association, class 1 heart failure patients are included. Exclusion Criteria: - Heart failure patients along with orthopedic problems. - Patients who have use pacemaker. - Patient who have recent acute myocardial infraction or revascularization less than 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High Intensity interval Training
High Intensity interval Training Frequency: 3-5 day per week Intensity: 60 to 80% of HRR. If atrial fibrillation present use RPE of 11-14 on a 6-20 scale. Time: total 30 mint time.6 mint exercise with high intensity and 2 mints of low intensity for active recovery until 30 mints complete. Type: walking and static cycling. Walking Frequency 3 -5 days per week Intensity : use RPE of 11-14. Time:30 mint total. 6 mint walk with high intensity and 2 mint walk with low intensity until 30mints completed.
Continuous Aerobic training
Continuous Aerobic training Frequency : 3-5 days per week. Intensity:40-70% of HHR. Time : initial 5-10 then 10-15 until 30mints without rest interval Type : walking and static cycling.

Locations

Country Name City State
Pakistan Railway General Hospital Rawalpindi Punjab

Sponsors (1)

Lead Sponsor Collaborator
Riphah International University

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary 6MWT Distance Changes from the baseline, 6 min walk test was used to measure Functional capacity. It is a sub maximal exercise test which can aid in assessing functional capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters which an individual covers in 6 min. 8 week
Primary Minnesota living with heart failure questionnaire MLWHFQ is commonly used health related quality of life questionnaires with heart failure. This is very easy to apply on patients and self-administered questionnaire. It has two components emotional and physical and total score. Each item is scored in a 6.likert scale (0 to 5), thus, the total score could range from 5 to 105, with higher scores indicating more significant impairment in health related quality of life. Changes from the basline will be measured 8 week
Primary Pulse Rate Changes from baseline, Pulse rate was measured per minute through pulse oximeter 8 week
Primary Oxygen Saturation (SpO2) Changes from baseline SPO2 was measured in percentage. Oxygen immersion is the division of oxygen-soaked hemoglobin with respect to add up to hemoglobin in the blood. Pulse oximeter measure it. 8 week
Primary Modified Borg dyspnea scale Changes from the Baseline, It is a subjective numeric scale ranging from 0 to 10, where 0 indicates "no dyspnea" and 10 indicates "unbearable dyspnea." A number is chosen by the patient in order to decide the best score that matches his level of dyspnea during physical activity. 8 week
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy